Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Expression profile of human porcine endogenous retrovirus A receptors (HuPAR‐1, HuPAR‐2) and transcription factor activator protein‐2γ (TFAP‐2C) genes in infected human fibroblasts—Model in vitro
Background
Xenotransplantation of porcine tissues raises concerns, especially in the context of the potential interspecies transmission of porcine endogenous retroviruses (PERVs). To date, the possibility of PERV infections of various human cells has been confirmed in vitro. PERVs infect cells coupling viral Env protein with adequate functional receptor on the surface of the host cell. So far, two PERV‐A receptors have been described in humans: HuPAR‐1 and HuPAR‐2. TFAP‐2C was described as one of the transcription factors engaged in the expression of HuPAR‐2.
Methods
Bacterial LPS, well known as a strong inflammation inducer, was used in this study to stimulate changes of the expression profile of inflammation‐related genes in human cells in vitro. The aim of the study was to investigate the expression profile of HuPAR‐1 and HuPAR‐2 and TFAP‐2C genes in human NHDF cells treated with LPS and/or infected with PERVs from PK15 cells. PERV infection and expression was confirmed by qPCR and RTqPCR. The expression of HuPAR‐1, HuPAR‐2, and TFAP‐2C genes was studied using HGU 133A 2.0 microarrays and RTqPCR.
Results
NHDF cells expressed both HuPAR‐1 and HuPAR‐2 genes with a higher expression of HuPAR‐1. LPS down‐regulated the expression of HuPAR‐1 and TFAP‐2C in NHDF cells, but had no effect on HuPAR‐2 expression. These changes induced by LPS were more pronounced in the presence of PERV infection.
Conclusion
As reported previously, treatment of NHDF cells with LPS decreased PERV‐A provirus integration and increased PERV‐A mRNA expression. PERV infection alone did not modulate the expression of HuPAR‐1, HuPAR‐2, and TFAP‐2C. This is the first study analyzing the expression profile of HuPAR‐1, HuPAR‐2, and TFAP‐2C in NHDF cells treated by LPS and/or infected by PERVs.